November 13, 2024

ASEICA organizes a “Week of Science in Cancer” with an international congress that will bring together 400 experts

The activities of the “Science Week” in Zaragoza will run from 12 to 16 November 2024. In addition to various informative days and meetings between patients and researchers, several grants will be awarded for cancer research worth a total of 345.000 euros.
November 11, 2024

A new drug promises to curb multiple sclerosis, Parkinson's and Alzheimer's

Researchers at University College London and Loyola University have developed a modified compound of cyclosporin A that blocks cyclophilin D in the brain, offering a new avenue for treating neurodegenerative diseases. Early animal studies show promising results.
November 8, 2024

The IIS Aragón participates in the REGIC Annual Conference

This year, the conference, organised by the Network of Clinical Research Management Entities (REGIC), is being held in Barcelona and the IIS Aragón is once again taking part in this important event.
November 7, 2024

A high-resolution macrostudy opens the door to tightening the noose in the fight against cancer

Alberto J. Schuhmacher, head of the Molecular Oncology Group at the IIS Aragón, reflects on cancer following the publication of the series of articles by the Nature group, which represent an unprecedented analysis of this disease, turning everything known upside down.
November 5, 2024

DIVE Medical helps diagnose visual and neurocognitive problems in childhood

The company, which has specialists in ophthalmology and optometry from the IIS Aragón and the IACS, uses technology based on artificial intelligence to objectively explore vision in any patient through gaze tracking.